News
-
Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID)
-
Sekur Private Data Ltd. Signs Distribution Agreement with Rich TV to Promote Sekur Privacy Solutions
-
Strategic Metals samples 2740 g/t silver and 8.37 g/t gold at its Triple Crown Project, Yukon
-
MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
-
bioEnergy Development Announces Bio-Waste Testing Pipeline at Capacity for Q3 2025
-
Delisting of the shares of artnet AG from the Frankfurt Stock Exchange as of August 22, 2025
-
Form 8.3 - The Vanguard Group, Inc.: NCC Group plc
-
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
-
Form 8.3 - The Vanguard Group, Inc.: Just Group plc
-
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
-
bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA américaine pour l’ajout du prélèvement nasal antérieur avec son test BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini
-
bioMérieux receives U.S. 510(k) clearance and CLIA-waiver for Anterior Nasal Swab specimens, an additional sample type for use with the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini
-
FREY REINFORCES ITS LEADING POSITION IN PREMIUM OUTLETS BY ACQUIRING THREE MAJOR SITES IN ITALY FOR €410 MILLION
-
FREY RENFORCE SON LEADERSHIP SUR LES PREMIUM OUTLETS AVEC L’ACQUISITION DE 3 SITES MAJEURS EN ITALIE POUR UN MONTANT DE 410 M€
-
Informations relatives au nombre total de droits de vote et d’actions 2025 07 31